Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Research Abstract |
HDL exerts a variety of anti-inflammatory and anti-atherogenic actions independently of the cholesterol metabolism. Here, we showed the cross-talk mechanism between statins and HDL in anti-inflammatory and anti-atherogenic actions, with a focus on scavenger receptor class B type I. Simvastatin treatment of HUVECs induces expression of SR-BI, which plays a critical role as a key molecule to enhance HDL-induced anti-inflammatory actions, including NOS activation and inhibition of adhesion molecule expression.
|